HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS - Patent 1133484

(19)

(11)

EP 1 133 484 A2

(12)

(88)	Date of publication A3:
	12.07.2001

(43)	Date of publication:
	19.09.2001 Bulletin 2001/38

(21)	Application number: 99934885.7

(22)	Date of filing: 20.07.1999

(51)	International Patent Classification (IPC)⁷: C07D 263/58, C07D 277/82, C07D 405/12, C07D 417/12, C07D 413/12, C07D 413/14, C07D 417/14, A61K 31/423, A61K 31/428, A61K 31/4184, C07D 235/30

(86)	International application number:
	PCT/GB9902/330

(87)	International publication number:
	WO 0005/223 (03.02.2000 Gazette 2000/05)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

23.07.1998 GB 9815970
23.07.1998 GB 9815972
22.06.1999 GB 9914441

(71)	Applicant: AstraZeneca AB
	151 85 Södertälje (SE)

(72)	Inventors:
	BRITTAIN, David Robert Macclesfield,Cheshire SK10 4TG (GB) JOHNSTONE, Craig Macclesfield,Cheshire SK10 4TG (GB) DAVIES, Gareth Morse Macclesfield,Cheshire SK10 4TG (GB) LARGE, Michael Stewart Macclesfield,Cheshire SK10 4TG (GB)

(74)	Representative: Bryant, Tracey et al
	AstraZeneca UK Limited,Global Intellectual Property,P.O. Box 272,Mereside,Alderley Park Macclesfield,Cheshire SK10 5GR Macclesfield,Cheshire SK10 5GR (GB)

(54)	HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS